Skip to content

Search across repositories

Find data for your analysis

602 datasets from 5 repositories. Filter by the analysis you need to run, not by what a repository says a dataset contains. How capability is measured.

602 of 602 datasets

  • Cancer Therapy and Clonal Hematopoiesis (MSK, Blood Adv 2023)
    OpenMachine-extracted
    msk_ch_2023cBioPortal42,714 casesMixed Cancer Types

    Why it fits: no access request needed

    Targeted DNA panel

    No citable accession, so reuse cannot be traced

  • NLST
    OpenMachine-extracted
    nlstIDC26,410 casesLung Cancer, Non-Cancer

    Why it fits: no access request needed

    Clinical dataRadiology imaging

    No citable accession, so reuse cannot be traced

  • MSK MetTropism (MSK, Cell 2021)
    OpenMachine-extracted
    msk_met_2021cBioPortal25,775 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 17.4 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • MSK-CHORD (MSK, Nature 2024)
    OpenMachine-extracted
    msk_chord_2024cBioPortal24,950 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 2.1 years; 4 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Cancer Therapy and Clonal Hematopoiesis (MSK, Nat Genet 2020)
    OpenMachine-extracted
    msk_ch_2020cBioPortal24,146 casesMixed Cancer Types

    Why it fits: no access request needed

    Targeted DNA panel

    No citable accession, so reuse cannot be traced

  • Foundation Medicine Adult Cancer Clinical Dataset (FM-AD)
    Underused opportunityMixedProject-curated
    FM-ADGDC18,004 casesNot Reported, Cystic, Mucinous and Serous Neoplasms

    18,004 patients profiled with a targeted clinical panel - the largest cohort in the Genomic Data Commons, with no informative vital status, no race data, and no treatment records.

    Clinical dataTargeted DNA panel

    6 articles analyzed these data

  • MSK-IMPACT Clinical Sequencing Cohort (MSK, Nat Med 2017)
    OpenMachine-extracted
    msk_impact_2017cBioPortal10,336 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 11.0 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Soft Tissue and Bone Sarcoma (MSK, Nat Commun 2022)
    OpenMachine-extracted
    sarcoma_msk_2022cBioPortal7,494 casesSoft Tissue

    Why it fits: no access request needed

    Structural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • CBIS-DDSM
    OpenMachine-extracted
    cbis_ddsmIDC6,671 casesBreast Cancer, Non-Cancer

    Why it fits: no access request needed

    Radiology imaging

    No citable accession, so reuse cannot be traced

  • MSK ctDNA Sequencing Cohort (MSK, Nature Medicine 2024)
    OpenMachine-extracted
    msk_ctdna_vte_2024cBioPortal5,567 casesMixed Cancer Types

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Breast-Cancer-Screening-DBT
    OpenMachine-extracted
    breast_cancer_screening_dbtIDC5,060 casesBreast Cancer, Non-Cancer

    Why it fits: no access request needed

    Clinical dataRadiology imaging

    No citable accession, so reuse cannot be traced

  • Molecular Characterization Initiative (MCI)
    MixedMachine-extracted
    CCDI-MCIGDC + IDC4,407 casesCystic, Mucinous and Serous Neoplasms, Granular Cell Tumors and Alveolar Soft Part Sarcomas

    Why it fits: 3 measurement types on the same cohort

    DNA methylationRadiology imagingWhole exome sequencing

    1 article analyzed these data

  • Breast Cancer (MSK, Nat Genet 2025)
    OpenMachine-extracted
    breast_msk_2025cBioPortal3,116 casesInvasive Breast Carcinoma

    Why it fits: survival endpoints, median follow-up 3.3 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • VICTRE
    OpenMachine-extracted
    victreIDC2,994 casesBreast Cancer

    Why it fits: no access request needed

    Radiology imaging

    No citable accession, so reuse cannot be traced

  • EAY131
    OpenMachine-extracted
    eay131IDC2,813 casesAdenocarcinoma, Adrenocortical Carcinoma

    Why it fits: no access request needed

    Clinical dataRadiology imaging

    No citable accession, so reuse cannot be traced

  • Acute Myeloid Leukemia
    MixedProject-curated
    TARGET-AMLGDC2,492 casesMyeloid Leukemias, Not Applicable

    Why it fits: treatment response recorded; survival endpoints, median follow-up 3.5 years; 9 measurement types on the same cohort

    2,492 children and young adults with acute myeloid leukaemia - the largest paediatric cancer genomics cohort in this corpus, with 3.5 years of median follow-up and therapeutic agents recorded for 35% of cases.

    Clinical dataCopy numberDNA methylationmicroRNABulk RNA sequencingStructural variants+3 more

    137 articles analyzed these data - 695 cite the paper

  • Pancreatic Adenocarcinoma (MSK, Nat Med 2024)
    OpenMachine-extracted
    pdac_msk_2024cBioPortal2,336 casesPancreas

    Why it fits: survival endpoints, median follow-up 13.5 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Lung Adenocarcinoma Met Organotropism (MSK, Cancer Cell 2023)
    OpenMachine-extracted
    luad_mskcc_2023_met_organotropismcBioPortal2,298 casesLung Adenocarcinoma

    Why it fits: survival endpoints, median follow-up 3.1 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Prostate Cancer (MSK, Clin Cancer Res 2024)
    OpenMachine-extracted
    prostate_msk_2024cBioPortal2,257 casesProstate

    Why it fits: survival endpoints, median follow-up 3.5 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Sarcoma (MSK, Nat Commun. 2022)
    OpenMachine-extracted
    sarcoma_mskcc_2022cBioPortal2,138 casesSoft Tissue

    Why it fits: survival endpoints, median follow-up 22.5 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Race Differences in Prostate Cancer (MSK, 2021)
    OpenMachine-extracted
    prad_msk_stopsack_2021cBioPortal2,069 casesProstate Adenocarcinoma

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Endometrial Cancer (MSK, Cancer Discovery 2023)
    OpenMachine-extracted
    ucec_ancestry_cds_msk_2023cBioPortal1,882 casesEndometrial Carcinoma

    Why it fits: no access request needed

    Copy numberTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • CPTAC-Brain, Head and Neck, Kidney, Lung, Pancreas, Uterus
    Underused opportunityMixedProject-curated
    CPTAC-3GDC1,866 casesNot Applicable, Transitional Cell Papillomas and Carcinomas

    Why it fits: treatment response recorded; survival endpoints, median follow-up 22.9 months; 9 measurement types on the same cohort

    1,866 tumors across six cancer types with genomics in the GDC and proteomics in the PDC - the largest prospectively collected proteogenomic cohort, with recurrence recorded for 78% of cases.

    Copy numberDNA methylationmicroRNABulk RNA sequencingSingle-cell RNA sequencingStructural variants+3 more

    25 articles analyzed these data - 688 cite the paper

  • CMMD
    OpenMachine-extracted
    cmmdIDC1,775 casesBreast Cancer

    Why it fits: no access request needed

    Clinical dataRadiology imaging

    No citable accession, so reuse cannot be traced

  • Breast Cancer (MSK, Cancer Cell 2018)
    OpenMachine-extracted
    breast_msk_2018cBioPortal1,756 casesBreast

    Why it fits: survival endpoints, median follow-up 3.4 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Cancer Cell Line Encyclopedia (Broad, 2019)
    OpenMachine-extracted
    ccle_broad_2019cBioPortal1,739 casesMixed Cancer Types

    Why it fits: 5 measurement types on the same cohort; majority Caucasian; no access request needed

    Copy numberProteome (mass spectrometry)Bulk RNA sequencingStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • TMB and Immunotherapy (MSK, Nat Genet 2019)
    OpenMachine-extracted
    tmb_mskcc_2018cBioPortal1,661 casesMixed Cancer Types

    Why it fits: survival endpoints, median follow-up 11.0 months; no access request needed

    Structural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Acute Lymphoblastic Leukemia - Phase II
    MixedMachine-extracted
    TARGET-ALL-P2GDC1,587 casesLymphoid Leukemias

    Why it fits: survival endpoints, median follow-up 7.7 years; 7 measurement types on the same cohort

    Clinical dataCopy numbermicroRNABulk RNA sequencingStructural variantsWhole genome sequencing+1 more

    42 articles analyzed these data

  • Colorectal Cancer (MSK, JNCI 2021)
    OpenMachine-extracted
    crc_eo_2020cBioPortal1,516 casesBowel

    Why it fits: 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Molecular Profiling to Predict Response to Treatment for Acute Lymphoblastic Leukemia
    Underused opportunityMixedProject-curated
    MP2PRT-ALLGDC1,510 casesAcute Lymphoblastic Leukemia, Lymphoid Leukemias

    Why it fits: treatment response recorded; survival endpoints, median follow-up 8.3 years; 6 measurement types on the same cohort

    1,510 children with acute lymphoblastic leukaemia from Children's Oncology Group trials, with whole genome sequencing, 8.4 years of median follow-up, and a named treatment regimen and response recorded for every single case.

    Clinical dataCopy numberBulk RNA sequencingStructural variantsWhole genome sequencingWhole exome sequencing

    0 articles analyzed these data

  • Prostate Adenocarcinoma (MSK, Eur Urol 2020)
    OpenMachine-extracted
    prad_cdk12_mskcc_2020cBioPortal1,465 casesProstate Adenocarcinoma

    Why it fits: 4 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Prostate Adenocarcinoma (MSK, Clin Cancer Res. 2022)
    OpenMachine-extracted
    prad_pik3r1_msk_2021cBioPortal1,417 casesProstate Adenocarcinoma

    Why it fits: survival endpoints, median follow-up 2.2 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • COVID-19-NY-SBU
    OpenMachine-extracted
    covid_19_ny_sbuIDC1,384 casesCOVID-19 (non-cancer)

    Why it fits: no access request needed

    Clinical dataRadiology imaging

    No citable accession, so reuse cannot be traced

  • Hepatocellular Carcinoma (MSK, Clin Cancer Res 2024)
    OpenMachine-extracted
    hcc_msk_2024cBioPortal1,370 casesHepatocellular Carcinoma

    Why it fits: survival endpoints, median follow-up 18.4 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Hepatobiliary Cancer (MSK, 2026)
    OpenMachine-extracted
    biliary_tract_msk_2026cBioPortal1,254 casesBiliary Tract

    Why it fits: survival endpoints, median follow-up 10.6 months; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Bladder Cancer (MSK, Cell Reports 2022)
    OpenMachine-extracted
    paired_bladder_2022cBioPortal1,244 casesBladder/Urinary Tract

    Why it fits: survival endpoints, median follow-up 2.6 years; 3 measurement types on the same cohort; no access request needed

    Copy numberStructural variantsTargeted DNA panel

    No citable accession, so reuse cannot be traced

  • Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial
    MixedMachine-extracted
    ALCHEMIST-ALCHGDC1,176 casesNot Reported

    Why it fits: 8 measurement types on the same cohort

    Clinical dataCopy numberHistopathology slidesmicroRNABulk RNA sequencingStructural variants+2 more

    0 articles analyzed these data

  • Prostate-MRI-US-Biopsy
    OpenMachine-extracted
    prostate_mri_us_biopsyIDC1,151 casesProstate Cancer

    Why it fits: no access request needed

    Radiology imaging

    No citable accession, so reuse cannot be traced

  • Chronic Lymphocytic Leukemia (Broad, Nature Genetics 2022)
    OpenMachine-extracted
    cll_broad_2022cBioPortal1,149 casesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Why it fits: survival endpoints, median follow-up 6.6 years; 4 measurement types on the same cohort; no access request needed

    Bulk RNA sequencingStructural variantsTargeted DNA panelTreatment records

    No citable accession, so reuse cannot be traced

  • Neuroblastoma
    MixedMachine-extracted
    TARGET-NBLGDC1,132 casesNot Applicable, Neuroepitheliomatous Neoplasms

    Why it fits: survival endpoints, median follow-up 6.2 years; 7 measurement types on the same cohort

    Clinical dataDNA methylationBulk RNA sequencingStructural variantsTargeted DNA panelWhole genome sequencing+1 more

    49 articles analyzed these data - 989 cite the paper